These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. On "Current role of antithrombotic agents in the treatment of acute coronary syndromes" (Semin Thromb Hemost 2004;30:627-632). Nessel CO Semin Thromb Hemost; 2005 Apr; 31(2):248. PubMed ID: 15852228 [No Abstract] [Full Text] [Related]
4. [Intravenous thrombolytic therapy in myocardial infarction (review)]. Staroverov II Ter Arkh; 2003; 75(10):80-3. PubMed ID: 14669614 [No Abstract] [Full Text] [Related]
6. Percutaneous coronary intervention or thrombolytics in ST-elevation infarction. What is the emperor really wearing? Dellborg M Scand Cardiovasc J; 2002 Aug; 36(4):197-200. PubMed ID: 12201965 [No Abstract] [Full Text] [Related]
7. What should a new thrombolytic bring us? Verheugt F Int J Clin Pract Suppl; 1998 Nov; 99():3-5. PubMed ID: 10344033 [No Abstract] [Full Text] [Related]
8. Successful outcome after evacuation of intracranial hematoma following thrombolysis in acute myocardial infarction. Al Khuwaitir TS; Wani BA; Dawood HA; Khan MA Saudi Med J; 2005 Jan; 26(1):130-2. PubMed ID: 15756370 [TBL] [Abstract][Full Text] [Related]
9. Questions linger in choice of thrombolytics. Berek B Hosp Technol Ser; 1994 Jul; 13(9):1-3. PubMed ID: 10134921 [No Abstract] [Full Text] [Related]
10. [Bolus fibrinolysis in acute myocardial infarction]. Zeymer U Dtsch Med Wochenschr; 2002 Oct; 127(40):2083-6. PubMed ID: 12373644 [No Abstract] [Full Text] [Related]
11. Safety profile of thrombolytic drugs. Maggioni AP; Fresco C Arq Bras Cardiol; 1995 Jul; 65(1):87-90. PubMed ID: 8546604 [No Abstract] [Full Text] [Related]
12. Management of bleeding in the patient receiving thrombolytic therapy for acute myocardial infarction: a nursing perspective. Kline E Heart Lung; 1988 Nov; 17(6 Pt 2):771-7. PubMed ID: 3056889 [No Abstract] [Full Text] [Related]
13. Fibrinolytic agents for the management of ST-segment elevation myocardial infarction. Hilleman DE; Tsikouris JP; Seals AA; Marmur JD Pharmacotherapy; 2007 Nov; 27(11):1558-70. PubMed ID: 17963464 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological reperfusion in acute myocardial infarction after ASSENT 3 and GUSTO V. Ferreira D Rev Port Cardiol; 2003; 22(7-8):1005-9. PubMed ID: 14587168 [No Abstract] [Full Text] [Related]
15. [Reduction of the size of a myocardial infarction using thrombolytic treatment. A myth impossible to dispel?]. Sánchez de Posada I; Casariego Rosón J Rev Clin Esp; 1986 Nov; 179(7):378-82. PubMed ID: 3541081 [No Abstract] [Full Text] [Related]
16. [Ischemic ictus during thrombolytic treatment in acute myocardial infarct]. Seijo-Martínez M; Pais A; Castro del Río M; Silva-Martínez M Rev Neurol; 2000 Oct 16-31; 31(8):798-9. PubMed ID: 11082894 [No Abstract] [Full Text] [Related]
17. Thrombolytic intervention and its effect on mortality in acute myocardium infarction. Mettinger KL Heart Lung; 1990 Mar; 19(2):213-5. PubMed ID: 2180864 [No Abstract] [Full Text] [Related]
18. What an interventional cardiologist should know about the pharmacological treatment of acute myocardial infarction. Verheugt FW Semin Interv Cardiol; 1999 Mar; 4(1):17-20. PubMed ID: 10406064 [TBL] [Abstract][Full Text] [Related]